Which has better earnings and valuation, ASTH or STN?

Stantec has higher revenue and earnings than Astrana Health. Stantec is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Astrana Health $3.18B 0.72 $22.49M $0.61 67.54 Stantec $5.83B 1.33 $343.11M $3.12 21.84

Does the media prefer ASTH or STN?

In the previous week, Stantec had 3 more articles in the media than Astrana Health. MarketBeat recorded 4 mentions for Stantec and 1 mentions for Astrana Health. Stantec's average media sentiment score of 0.21 beat Astrana Health's score of 0.00 indicating that Stantec is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Astrana Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Stantec 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor Z or ASTH?

In the previous week, Zillow Group had 19 more articles in the media than Astrana Health. MarketBeat recorded 20 mentions for Zillow Group and 1 mentions for Astrana Health. Zillow Group's average media sentiment score of 0.25 beat Astrana Health's score of 0.00 indicating that Zillow Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zillow Group 5 Very Positive mention(s) 0 Positive mention(s) 13 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Astrana Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to ZG or ASTH?

In the previous week, Zillow Group had 13 more articles in the media than Astrana Health. MarketBeat recorded 14 mentions for Zillow Group and 1 mentions for Astrana Health. Zillow Group's average media sentiment score of 0.19 beat Astrana Health's score of 0.00 indicating that Zillow Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zillow Group 2 Very Positive mention(s) 0 Positive mention(s) 12 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Astrana Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher earnings & valuation, ASTH or BILI?

Bilibili has higher revenue and earnings than Astrana Health. Bilibili is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Astrana Health $3.18B 0.72 $22.49M $0.61 67.54 Bilibili $4.34B 1.53 $170.67M $0.45 35.47

Does the media refer more to ASTH or BILI?

In the previous week, Bilibili had 8 more articles in the media than Astrana Health. MarketBeat recorded 9 mentions for Bilibili and 1 mentions for Astrana Health. Astrana Health's average media sentiment score of 0.00 beat Bilibili's score of -0.69 indicating that Astrana Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Astrana Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Bilibili 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 4 Very Negative mention(s) Negative

Does the media favor HQY or ASTH?

In the previous week, HealthEquity had 4 more articles in the media than Astrana Health. MarketBeat recorded 5 mentions for HealthEquity and 1 mentions for Astrana Health. HealthEquity's average media sentiment score of 1.60 beat Astrana Health's score of 0.00 indicating that HealthEquity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Astrana Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Astrana Health (ASTH) Competitors

$41.20 +1.61 (+4.07%)

Closing price 04:00 PM Eastern

Extended Trading

$41.50 +0.31 (+0.74%)

As of 07:55 PM Eastern

Compare

ASTH vs. STN, Z, ZG, BILI, and HQY

Should you buy Astrana Health stock or one of its competitors? MarketBeat compares Astrana Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Astrana Health include Stantec (STN), Zillow Group (Z), Zillow Group (ZG), Bilibili (BILI), and HealthEquity (HQY). These companies are all part of the "business services" industry.

How does Astrana Health compare to Stantec?

Astrana Health (NASDAQ:ASTH) and Stantec (NYSE:STN) are both mid-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, media sentiment, institutional ownership, dividends, profitability and risk.

Stantec has a net margin of 5.92% compared to Astrana Health's net margin of 0.86%. Stantec's return on equity of 19.37% beat Astrana Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Astrana Health	0.86%	9.22%	3.54%
Stantec	5.92%	19.37%	8.03%

Stantec has higher revenue and earnings than Astrana Health. Stantec is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrana Health	$3.18B	0.72	$22.49M	$0.61	67.54
Stantec	$5.83B	1.33	$343.11M	$3.12	21.84

In the previous week, Stantec had 3 more articles in the media than Astrana Health. MarketBeat recorded 4 mentions for Stantec and 1 mentions for Astrana Health. Stantec's average media sentiment score of 0.21 beat Astrana Health's score of 0.00 indicating that Stantec is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Astrana Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Stantec	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

52.8% of Astrana Health shares are held by institutional investors. Comparatively, 63.9% of Stantec shares are held by institutional investors. 20.3% of Astrana Health shares are held by insiders. Comparatively, 0.5% of Stantec shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Astrana Health has a beta of 1, meaning that its stock price has a similar volatility profile to the broader market.Comparatively, Stantec has a beta of 0.98, meaning that its stock price is 2% less volatile than the broader market.

Astrana Health presently has a consensus price target of $45.00, indicating a potential upside of 9.22%. Stantec has a consensus price target of $175.00, indicating a potential upside of 156.82%. Given Stantec's higher probable upside, analysts clearly believe Stantec is more favorable than Astrana Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78
Stantec	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

Summary

Stantec beats Astrana Health on 11 of the 16 factors compared between the two stocks.

How does Astrana Health compare to Zillow Group?

Zillow Group (NASDAQ:Z) and Astrana Health (NASDAQ:ASTH) are both mid-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, earnings, dividends, analyst recommendations, valuation and profitability.

In the previous week, Zillow Group had 19 more articles in the media than Astrana Health. MarketBeat recorded 20 mentions for Zillow Group and 1 mentions for Astrana Health. Zillow Group's average media sentiment score of 0.25 beat Astrana Health's score of 0.00 indicating that Zillow Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zillow Group	5 Very Positive mention(s)	0 Positive mention(s)	13 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Astrana Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Zillow Group has higher earnings, but lower revenue than Astrana Health. Astrana Health is trading at a lower price-to-earnings ratio than Zillow Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zillow Group	$2.58B	2.70	$23M	$0.25	122.00
Astrana Health	$3.18B	0.72	$22.49M	$0.61	67.54

Zillow Group has a beta of 1.97, suggesting that its share price is 97% more volatile than the broader market. Comparatively, Astrana Health has a beta of 1, suggesting that its share price has a similar volatility profile to the broader market.

71.0% of Zillow Group shares are held by institutional investors. Comparatively, 52.8% of Astrana Health shares are held by institutional investors. 23.8% of Zillow Group shares are held by insiders. Comparatively, 20.3% of Astrana Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Zillow Group has a net margin of 2.27% compared to Astrana Health's net margin of 0.86%. Astrana Health's return on equity of 9.22% beat Zillow Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zillow Group	2.27%	1.41%	1.22%
Astrana Health	0.86%	9.22%	3.54%

Zillow Group currently has a consensus price target of $76.00, suggesting a potential upside of 149.18%. Astrana Health has a consensus price target of $45.00, suggesting a potential upside of 9.22%. Given Zillow Group's higher probable upside, equities analysts plainly believe Zillow Group is more favorable than Astrana Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zillow Group	1 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.53
Astrana Health	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78

Summary

Zillow Group beats Astrana Health on 11 of the 17 factors compared between the two stocks.

How does Astrana Health compare to Zillow Group?

Zillow Group (NASDAQ:ZG) and Astrana Health (NASDAQ:ASTH) are both mid-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, risk, valuation, profitability, dividends, analyst recommendations, media sentiment and institutional ownership.

20.3% of Zillow Group shares are owned by institutional investors. Comparatively, 52.8% of Astrana Health shares are owned by institutional investors. 29.9% of Zillow Group shares are owned by company insiders. Comparatively, 20.3% of Astrana Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Zillow Group currently has a consensus target price of $69.43, suggesting a potential upside of 127.19%. Astrana Health has a consensus target price of $45.00, suggesting a potential upside of 9.22%. Given Zillow Group's higher possible upside, research analysts clearly believe Zillow Group is more favorable than Astrana Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zillow Group	1 Sell rating(s)	12 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.46
Astrana Health	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78

Zillow Group has a net margin of 2.27% compared to Astrana Health's net margin of 0.86%. Astrana Health's return on equity of 9.22% beat Zillow Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zillow Group	2.27%	1.41%	1.22%
Astrana Health	0.86%	9.22%	3.54%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zillow Group	$2.58B	2.71	$23M	$0.25	122.24
Astrana Health	$3.18B	0.72	$22.49M	$0.61	67.54

Zillow Group has a beta of 1.94, suggesting that its share price is 94% more volatile than the broader market. Comparatively, Astrana Health has a beta of 1, suggesting that its share price has a similar volatility profile to the broader market.

In the previous week, Zillow Group had 13 more articles in the media than Astrana Health. MarketBeat recorded 14 mentions for Zillow Group and 1 mentions for Astrana Health. Zillow Group's average media sentiment score of 0.19 beat Astrana Health's score of 0.00 indicating that Zillow Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zillow Group	2 Very Positive mention(s)	0 Positive mention(s)	12 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Astrana Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Zillow Group beats Astrana Health on 10 of the 16 factors compared between the two stocks.

How does Astrana Health compare to Bilibili?

Astrana Health (NASDAQ:ASTH) and Bilibili (NASDAQ:BILI) are both mid-cap business services companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, media sentiment, profitability, dividends, valuation, analyst recommendations and institutional ownership.

Bilibili has higher revenue and earnings than Astrana Health. Bilibili is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrana Health	$3.18B	0.72	$22.49M	$0.61	67.54
Bilibili	$4.34B	1.53	$170.67M	$0.45	35.47

Astrana Health has a beta of 1, suggesting that its share price has a similar volatility profile to the broader market.Comparatively, Bilibili has a beta of 0.71, suggesting that its share price is 29% less volatile than the broader market.

52.8% of Astrana Health shares are owned by institutional investors. Comparatively, 16.1% of Bilibili shares are owned by institutional investors. 20.3% of Astrana Health shares are owned by company insiders. Comparatively, 22.2% of Bilibili shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Bilibili has a net margin of 4.58% compared to Astrana Health's net margin of 0.86%. Bilibili's return on equity of 10.81% beat Astrana Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Astrana Health	0.86%	9.22%	3.54%
Bilibili	4.58%	10.81%	4.04%

In the previous week, Bilibili had 8 more articles in the media than Astrana Health. MarketBeat recorded 9 mentions for Bilibili and 1 mentions for Astrana Health. Astrana Health's average media sentiment score of 0.00 beat Bilibili's score of -0.69 indicating that Astrana Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Astrana Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Bilibili	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	4 Very Negative mention(s)	Negative

Astrana Health presently has a consensus price target of $45.00, suggesting a potential upside of 9.22%. Bilibili has a consensus price target of $30.78, suggesting a potential upside of 92.84%. Given Bilibili's stronger consensus rating and higher possible upside, analysts plainly believe Bilibili is more favorable than Astrana Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78
Bilibili	1 Sell rating(s)	0 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.80

Summary

Bilibili beats Astrana Health on 11 of the 16 factors compared between the two stocks.

How does Astrana Health compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and Astrana Health (NASDAQ:ASTH) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, analyst recommendations and dividends.

HealthEquity has a beta of 0.21, indicating that its share price is 79% less volatile than the broader market. Comparatively, Astrana Health has a beta of 1, indicating that its share price has a similar volatility profile to the broader market.

99.6% of HealthEquity shares are held by institutional investors. Comparatively, 52.8% of Astrana Health shares are held by institutional investors. 1.6% of HealthEquity shares are held by company insiders. Comparatively, 20.3% of Astrana Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

HealthEquity presently has a consensus target price of $110.57, suggesting a potential upside of 30.21%. Astrana Health has a consensus target price of $45.00, suggesting a potential upside of 9.22%. Given HealthEquity's stronger consensus rating and higher probable upside, research analysts clearly believe HealthEquity is more favorable than Astrana Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.86
Astrana Health	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78

HealthEquity has a net margin of 17.25% compared to Astrana Health's net margin of 0.86%. HealthEquity's return on equity of 14.75% beat Astrana Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.25%	14.75%	9.22%
Astrana Health	0.86%	9.22%	3.54%

HealthEquity has higher earnings, but lower revenue than Astrana Health. HealthEquity is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	5.41	$215.20M	$2.67	31.81
Astrana Health	$3.18B	0.72	$22.49M	$0.61	67.54

In the previous week, HealthEquity had 4 more articles in the media than Astrana Health. MarketBeat recorded 5 mentions for HealthEquity and 1 mentions for Astrana Health. HealthEquity's average media sentiment score of 1.60 beat Astrana Health's score of 0.00 indicating that HealthEquity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Astrana Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

HealthEquity beats Astrana Health on 13 of the 17 factors compared between the two stocks.

Get Astrana Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ASTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ASTH vs. The Competition

Export

Metric	Astrana Health	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2.21B	$5.71B	$6.45B	$12.39B
Dividend Yield	N/A	1.57%	2.69%	5.83%
P/E Ratio	67.54	36.49	24.92	23.98
Price / Sales	0.72	23.09	529.01	109.54
Price / Cash	14.07	16.98	44.82	54.51
Price / Book	2.92	3.27	10.79	6.50
Net Income	$22.49M	$218.81M	$3.56B	$336.88M
7 Day Performance	7.35%	1.41%	1.67%	-0.22%
1 Month Performance	8.85%	3.26%	0.43%	0.77%
1 Year Performance	64.34%	20.35%	32.84%	31.57%

Astrana Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ASTH Astrana Health	2.7729 of 5 stars	$41.20 +4.1%	$45.00 +9.2%	+65.0%	$2.21B	$3.18B	67.54	3,000	News Coverage Positive News
STN Stantec	4.6867 of 5 stars	$74.00 +0.8%	$175.00 +136.5%	-34.8%	$8.38B	$5.83B	23.72	34,000
Z Zillow Group	4.5224 of 5 stars	$35.45 +1.9%	$77.00 +117.2%	-55.6%	$7.96B	$2.58B	141.80	5,720
ZG Zillow Group	4.276 of 5 stars	$35.83 +3.0%	$71.24 +98.8%	-54.3%	$7.96B	$2.58B	143.32	7,068
BILI Bilibili	4.0359 of 5 stars	$17.61 -1.9%	$30.78 +74.8%	-15.1%	$7.45B	$4.34B	39.13	8,423	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ASTH) was last updated on 6/23/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Astrana Health (ASTH) Competitors

ASTH vs. STN, Z, ZG, BILI, and HQY

How does Astrana Health compare to Stantec?

Summary

How does Astrana Health compare to Zillow Group?

Summary

How does Astrana Health compare to Zillow Group?

Summary

How does Astrana Health compare to Bilibili?

Summary

How does Astrana Health compare to HealthEquity?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ASTH vs. The Competition

Astrana Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Astrana Health (ASTH) Competitors

ASTH vs. STN, Z, ZG, BILI, and HQY

How does Astrana Health compare to Stantec?

Is ASTH or STN more profitable?

Which has better earnings and valuation, ASTH or STN?

Does the media prefer ASTH or STN?

Do institutionals and insiders hold more shares of ASTH or STN?

Which has more volatility & risk, ASTH or STN?

Do analysts rate ASTH or STN?

Summary

How does Astrana Health compare to Zillow Group?

Does the media favor Z or ASTH?

Which has preferable earnings & valuation, Z or ASTH?

Which has more volatility & risk, Z or ASTH?

Do institutionals & insiders have more ownership in Z or ASTH?

Is Z or ASTH more profitable?

Do analysts prefer Z or ASTH?

Summary

How does Astrana Health compare to Zillow Group?

Do insiders & institutionals hold more shares of ZG or ASTH?

Do analysts recommend ZG or ASTH?

Is ZG or ASTH more profitable?

Which has better valuation and earnings, ZG or ASTH?

Which has more risk & volatility, ZG or ASTH?

Does the media refer more to ZG or ASTH?

Summary

How does Astrana Health compare to Bilibili?

Which has higher earnings & valuation, ASTH or BILI?

Which has more risk and volatility, ASTH or BILI?

Do insiders and institutionals hold more shares of ASTH or BILI?

Is ASTH or BILI more profitable?

Does the media refer more to ASTH or BILI?

Do analysts recommend ASTH or BILI?

Summary

How does Astrana Health compare to HealthEquity?

Which has more volatility and risk, HQY or ASTH?

Do insiders & institutionals have more ownership in HQY or ASTH?

Do analysts recommend HQY or ASTH?

Is HQY or ASTH more profitable?

Which has higher valuation & earnings, HQY or ASTH?

Does the media favor HQY or ASTH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ASTH vs. The Competition

Astrana Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools